Rachel S. Nargi

4.9k total citations · 2 hit papers
15 papers, 997 citations indexed

About

Rachel S. Nargi is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Rachel S. Nargi has authored 15 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Rachel S. Nargi's work include Viral Infections and Vectors (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Rachel S. Nargi is often cited by papers focused on Viral Infections and Vectors (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Rachel S. Nargi collaborates with scholars based in United States, Germany and Australia. Rachel S. Nargi's co-authors include James E. Crowe, Rachel E. Sutton, Robert H. Carnahan, Naveenchandra Suryadevara, Elad Binshtein, Pavlo Gilchuk, Seth J. Zost, Paul W. Rothlauf, Sean P. J. Whelan and Rachel Eguia and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Rachel S. Nargi

15 papers receiving 983 citations

Hit Papers

Complete Mapping of Mutations to the SARS-CoV-2 Spike Rec... 2020 2026 2022 2024 2020 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
    2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
  2. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    2021 215 citations Naveenchandra Suryadevara, Swathi Shrihari et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel S. Nargi United States 10 840 316 171 132 131 15 997
Benjamin O. Fulton United States 5 685 0.8× 218 0.7× 128 0.7× 104 0.8× 122 0.9× 5 834
Kristen E. Pascal United States 5 814 1.0× 259 0.8× 140 0.8× 166 1.3× 150 1.1× 6 1.0k
Panke Qu United States 15 664 0.8× 215 0.7× 65 0.4× 121 0.9× 90 0.7× 15 740
Tandile Hermanus South Africa 10 919 1.1× 389 1.2× 222 1.3× 113 0.9× 182 1.4× 24 1.5k
Kshitij Wagh United States 16 568 0.7× 294 0.9× 173 1.0× 68 0.5× 121 0.9× 28 1.1k
Keara D. Malone United States 5 1.1k 1.3× 382 1.2× 130 0.8× 169 1.3× 76 0.6× 5 1.2k
François Kien Hong Kong 10 917 1.1× 274 0.9× 75 0.4× 242 1.8× 201 1.5× 13 1.2k
Sham Nambulli United States 11 761 0.9× 272 0.9× 244 1.4× 132 1.0× 202 1.5× 21 1.0k
Rachel Eguia United States 12 1.3k 1.6× 446 1.4× 166 1.0× 232 1.8× 192 1.5× 13 1.6k

Countries citing papers authored by Rachel S. Nargi

Since Specialization
Citations

This map shows the geographic impact of Rachel S. Nargi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel S. Nargi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel S. Nargi more than expected).

Fields of papers citing papers by Rachel S. Nargi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel S. Nargi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel S. Nargi. The network helps show where Rachel S. Nargi may publish in the future.

Co-authorship network of co-authors of Rachel S. Nargi

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel S. Nargi. A scholar is included among the top collaborators of Rachel S. Nargi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel S. Nargi. Rachel S. Nargi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yoder, Sandra, Rachel S. Nargi, Nurgun Kose, et al.. (2023). Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. Journal of the Pediatric Infectious Diseases Society. 12(5). 298–305. 1 indexed citations
2.
Shiakolas, Andrea R., Kevin J. Kramer, Nicole V. Johnson, et al.. (2022). Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nature Biotechnology. 40(8). 1270–1275. 27 indexed citations
3.
Schoeder, Clara T., Pavlo Gilchuk, Amandeep K. Sangha, et al.. (2022). Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathogens. 18(5). e1010518–e1010518. 8 indexed citations
4.
Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 184(9). 2316–2331.e15. 215 indexed citations breakdown →
5.
Gilchuk, Pavlo, Charles D. Murin, Robert W. Cross, et al.. (2021). Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 184(22). 5593–5607.e18. 23 indexed citations
6.
Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. The Journal of Immunology. 206(1_Supplement). 30.13–30.13. 5 indexed citations
7.
Williamson, Lauren E., Theron Gilliland, Pramod Kumar Yadav, et al.. (2020). Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection. Cell. 183(7). 1884–1900.e23. 27 indexed citations
8.
Finn, Jessica A., Jinhui Dong, Alexander M. Sevy, et al.. (2020). Identification of Structurally Related Antibodies in Antibody Sequence Databases Using Rosetta-Derived Position-Specific Scoring. Structure. 28(10). 1124–1130.e5. 9 indexed citations
9.
Bozhanova, Nina G., Amandeep K. Sangha, Alexander M. Sevy, et al.. (2020). Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions. Proceedings of the National Academy of Sciences. 117(49). 31142–31148. 9 indexed citations
10.
Dong, Jinhui, Robert W. Cross, Michael P. Doyle, et al.. (2020). Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 183(6). 1536–1550.e17. 41 indexed citations
11.
Greaney, Allison J., Tyler N. Starr, Pavlo Gilchuk, et al.. (2020). Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host & Microbe. 29(1). 44–57.e9. 568 indexed citations breakdown →
12.
Sevy, Alexander M., Iuliia M. Gilchuk, Benjamin P. Brown, et al.. (2020). Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza Variants. Structure. 28(10). 1114–1123.e4. 19 indexed citations
13.
14.
Zhao, Haiyan, Lily Xu, Robin Bombardi, et al.. (2019). Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge. The Journal of Experimental Medicine. 217(2). 26 indexed citations
15.
Nargi, Rachel S., et al.. (2019). Role of antibody heavy and light chain interface residues in affinity maturation of binding to HIV envelope glycoprotein. Molecular Systems Design & Engineering. 4(4). 737–746. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin O. Fulton Breakdown of academic impact, for papers by Kristen E. Pascal Breakdown of academic impact, for papers by Panke Qu Breakdown of academic impact, for papers by Tandile Hermanus Breakdown of academic impact, for papers by Kshitij Wagh Breakdown of academic impact, for papers by Keara D. Malone Breakdown of academic impact, for papers by François Kien Breakdown of academic impact, for papers by Sham Nambulli Breakdown of academic impact, for papers by Rachel Eguia
Rankless by CCL
2026